Scientific work

Uzm. Dr. Kımıa Çepni

27 publications. The source of the information is stated next to each publication.

Back to profile

  1. Effects of rectal retractor use on dosimetric parameters, treatment-related adverse events, and clinical outcomes of cervical cancer brachytherapy: A retrospective tertiary-centre study

    Clinical and Translational Radiation Oncology, 2026

    DOI 10.1016/j.ctro.2026.101302 PMID 42871204 Open-access full textSource: OpenAlex

  2. Association of Pretreatment Hemoglobin and Lymphocyte Levels with Survival Outcomes in Cervical Cancer Patients Undergoing Chemoradiotherapy

    Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 2026

    DOI 10.38136/jgon.1967510 Open-access full textSource: ORCID

  3. Impact of Response Rates on Overall Survival Following Chemoradiotherapy with or Without Surgery in Esophageal Cancer

    Cerrahpaşa Medical Journal, 2026

    DOI 10.5152/cjm.2026.25079 Open-access full textSource: ORCID

  4. Efficacy and Safety of Radiotherapy in Head and Neck Paragangliomas: A Retrospective 23-Year Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15031062 PMID 41682742 1 citation (Europe PMC) Open-access full textSource: ORCID

  5. Predictive Role of Pre-Radiotherapy D-Dimer and Inflammatory Markers in Monitoring Outcomes After Treatment in Hormone-Positive Breast Cancer: A Retrospective Cohort Study

    Diagnostics, 2026

    DOI 10.3390/diagnostics16040582 PMID 41750730 Open-access full textSource: ORCID

  6. Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Esophageal Cancer Following Neoadjuvant Chemoradiotherapy

    Kasav international journal of health sciences., 2026

    DOI 10.29228/kijhs.95619 Source: ORCID

  7. A multidimensional benchmarking framework for large language models in oncologic decision making

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61195-1 PMID 42481610 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  8. Prognostic Significance of Lymphocyte Percentage and IL-6 Level in Patients Undergoing Radiotherapy for Advanced Lung Cancer

    Bezmialem Science, 2026

    DOI 10.14235/bas.galenos.2025.98624 Open-access full textSource: OpenAlex

  9. Comparative validation of prognostic indices in brain metastases receiving cranial radiotherapy

    Oncology in Clinical Practice, 2025

    DOI 10.5603/ocp.108320 Open-access full textSource: ORCID

  10. Prognostic value of D-dimer in treatment and follow up for patients who underwent radiotherapy in advanced lung cancer

    Plos One, 2025

    DOI 10.1371/journal.pone.0333085 PMID 40986549 Open-access full textSource: ORCID

  11. Burnout Levels and Contributing Factors Among Radiation Oncology Resident Physicians

    Bezmialem Science, 2025

    DOI 10.14235/bas.galenos.2025.80090 Open-access full textSource: OpenAlex

  12. Results of low dose helical arc intensive modulated radiotherapy (IMRT) in brain metastases localized in brainstem

    JOURNAL OF RADIATION ONCOLOGY AND PALLIATION, 2024

    DOI 10.29228/jrop.87999 Source: OpenAlex

  13. Evaluation of Depression, Anxiety, and Sexual Function in Rectal Cancer Patients Before and After Neoadjuvant Chemoradiotherapy

    Journal of Gastrointestinal Cancer, 2023

    DOI 10.1007/s12029-023-00939-y PMID 37280447 3 citations (OpenAlex) Source: OpenAlex

  14. Selective local postoperative radiotherapy for T3–T4 N0 laryngeal cancer

    Strahlentherapie und Onkologie, 2022

    DOI 10.1007/s00066-022-01999-y PMID 36074137 5 citations (Europe PMC) Source: ORCID

  15. The investigation of fetal dose for mantle field irradiation of Hodgkin’s disease

    DOAJ (DOAJ: Directory of Open Access Journals), 2019

    DOI 10.2399/ctd.08.056 Source: OpenAlex

  16. Comparison of changes in renal function with dosimetric parameters in gastric cancer patients treated with adjuvant chemoradiotherapy

    Japanese Journal of Radiology, 2017

    DOI 10.1007/s11604-017-0692-1 PMID 29064001 2 citations (OpenAlex) Source: OpenAlex

  17. Marginal zone lymphoma in the breast. A case report and review of the literature

    2016

    DOI 10.7353/polmed.2016.123.053 Source: OpenAlex

  18. Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması

    DergiPark (Istanbul University), 2014

    Open-access full textSource: OpenAlex

  19. Randomized Trial of Oral Misoprostol Treatment for Cervical Ripening Before Tandem Application in Cervix Cancer

    International Journal of Radiation Oncology*Biology*Physics, 2011

    DOI 10.1016/j.ijrobp.2010.06.051 PMID 21377295 8 citations (OpenAlex) Source: OpenAlex

  20. The investigation of fetal doses in mantle field irradiation

    Radiation Protection Dosimetry, 2009

    DOI 10.1093/rpd/ncp034 PMID 19299479 4 citations (OpenAlex) Source: OpenAlex

  21. P-534 Results of high dose of gemcitabine + cisplatin combination in metastatic non-small cell lung cancer

    Lung Cancer, 2005

    DOI 10.1016/s0169-5002(05)81027-x Source: OpenAlex

  22. 000204: RESULTS OF ADJUVANT BRACHYTHERAPY OF STAGE IB ENDOMETRIAL CARCINOMA

    International Journal of Gynecological Cancer, 2005

    DOI 10.1136/ijgc-00009577-200509001-00200 Open-access full textSource: OpenAlex

  23. Tandem application with transvaginal ultrasound guidance

    International Journal of Radiation Oncology*Biology*Physics, 2004

    DOI 10.1016/j.ijrobp.2003.10.028 PMID 15093916 14 citations (OpenAlex) Source: OpenAlex

  24. Results of concurrent chemoradiotherapy with high-dose vinorelbine and amifostine in medically inoperable and stage IIIB NSCLC patients

    2004

    Source: OpenAlex

  25. The consolidation study with docetaxel after combined chemoradiotherapy in Stage III B non-small cell lung carcinoma

    2004

    Source: OpenAlex

  26. The 3-years survival results of concurrent chemoradiotherapy and vinorelbine in medically inoperable and Stage III B NSCLC patients

    2004

    Source: OpenAlex

  27. Pilomatriks karsinoma: Olgu sunumu

    Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, 2003

    Source: OpenAlex